查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2016609

轉染技術市場規模、佔有率、趨勢和預測：按產品類型、應用、轉染方法、技術、最終用戶和地區分類，2026-2034年

Transfection Technologies Market Size, Share, Trends and Forecast by Product Type, Application, Transfection Method, Technology, End-User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3個工作天內

價格

2025年全球轉染技術市場規模為13.486億美元。展望未來，IMARC Group預測，該市場將以6.56%的複合年成長率從2026年成長至2034年，到2034年達到24.313億美元。目前，北美市場主導地位，2025年市佔率達39.3%。轉染技術市場佔有率的成長得益於強大的研究基礎設施、高額的醫療保健支出、先進基因組分析工具的廣泛應用、生物技術和製藥公司的強大實力，以及政府對基因研究和藥物研發的支持。

轉染技術是指將核酸（例如去氧核糖核酸(DNA)、核糖核酸 (RNA) 和寡核苷酸）人工導入細胞的過程。該技術可透過多種物理、化學和生物學方法實現，並可用於改變細胞的特定性質。其方法包括共轉染、電穿孔、陽離子脂質體轉染及體內轉染等。此技術廣泛應用於各種基因組學研究，例如基因表現、篩檢、 RNA干擾和體內研究，以及病毒和蛋白質的生物生產。

癌症和各種文明病的日益普及是推動市場成長的主要因素之一。此外，基於試劑的方法的普及也促進了市場成長。與傳統技術相比，基於試劑的轉染操作更簡單、成本更低。因此，諸如生物切割技術、顯微注射和雷射轉染等方法正受到全球的廣泛關注。細胞研究和治療方法發現領域的各種技術進步是推動市場成長的另一個主要因素。因此，基因轉殖研究主要在體內條件下進行，旨在開發新的治療藥物和其他應用。此外，政府和私營機構增加對大規模轉染設施建設的投資，以及在蛋白質療法領域進行廣泛的研發活動，預計也將進一步推動市場擴張。

市場區隔

本報告分析了全球轉染技術市場各細分領域的關鍵趨勢，並提供了 2026 年至 2034 年的全球、區域和國家特定預測。該報告根據產品類型、應用、轉染方法、技術和最終用戶對市場進行了細分。

按產品類型細分

  • 試劑
  • 裝置
  • 其他

按用途細分

  • 藥物輸送
  • 生物醫學研究
  • 蛋白質生產
  • 其他

依轉染方法分類

  • 脂質體
  • 電穿孔
  • 核轉染
  • 共轉染
  • 陽離子脂質轉染
  • 體內轉染
  • 其他

依技術分類

  • 物理轉染
  • 生化轉染
  • 利用病毒載體進行轉染

按最終用戶分類

  • 研究中心和學術機構
  • 醫院和診所
  • 製藥和生物技術公司
  • 其他

按地區分類

  • 北美洲
  • 我們
  • 加拿大
  • 亞太地區
  • 中國
  • 日本
  • 印度
  • 韓國
  • 澳洲
  • 印尼
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 俄羅斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中東和非洲

競爭格局

該報告還分析了市場的競爭格局，主要企業介紹了安捷倫科技、Bio-Rad Laboratories、Lonza Group AG、MaxSight、Myras Bio LLC、Polyplus Transfections、Promega Corporation、羅氏控股、Sigma-Aldrich 和賽默飛世爾科技等主要參與者。

本報告解答的主要問題

1. 到 2025 年，全球轉染技術市場規模將達到多少？

2. 2026 年至 2034 年全球轉染技術市場的預期成長率為何？

3. 推動全球轉染技術市場發展的主要因素是什麼？

4. COVID-19 對全球轉染技術市場產生了哪些影響？

5. 全球轉染技術市場依產品類型分類的組成是什麼？

6. 全球轉染技術市場按應用領域分類的組成是什麼？

7. 全球轉染技術市場依轉染方法分類的組成是什麼？

8. 全球轉染技術市場依技術分類的組成是什麼？

9. 全球轉染技術市場的主要區域有哪些？

10. 全球轉染技術市場的主要參與者/公司有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球轉染技術市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品類型分類

  • 試劑
  • 裝置
  • 其他

第7章 市場區隔：依應用領域分類

  • 藥物輸送
  • 生物醫學研究
  • 蛋白質生產
  • 其他

第8章 市場區隔：依轉染法分類

  • 脂質體
  • 電穿孔
  • 核轉染
  • 共轉染
  • 陽離子脂質轉染
  • 體內轉染
  • 其他

第9章 市場區隔：依技術分類

  • 物理轉染
  • 生化轉染
  • 利用病毒載體進行轉染

第10章 市場區隔：依最終用戶分類

  • 研究機構和學術機構
  • 醫院和診所
  • 製藥和生物技術公司
  • 其他

第11章 市場區隔：按地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第12章 SWOT 分析

第13章：價值鏈分析

第14章：波特五力分析

第15章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Agilent Technologies Inc.
    • Altogen Biosystems
    • Amsbio
    • Bio-RAD Laboratories Inc.
    • Lonza Group AG
    • Maxcyte Inc.
    • Mirus Bio LLC
    • Promega Corporation
    • QIAGEN NV
    • Sartorius AG
    • SignaGen Laboratories
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A2188

The global transfection technologies market size was valued at USD 1,348.6 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 2,431.3 Million by 2034, exhibiting a CAGR of 6.56% from 2026-2034. North America currently dominates the market, holding a market share of 39.3% in 2025. The transfection technologies market share is growing because of strong research infrastructure, high healthcare spending, widespread adoption of advanced genomic tools, significant biotech and pharma presence, and supportive government funding for genetic research and drug discovery.

Transfection technology refers to the process of artificially introducing nucleic acid, such as Deoxyribonucleic Acid (DNA), Ribonucleic Acid (RNA) and oligonucleotides, into the cells. It is introduced using various physical, chemical and biological methods, which can assist in modifying certain properties of the cell. It involves various methods, including cotransfection, electroporation, cationic lipid transfection and in-vivo transfection. This process is commonly used for various genomic studies that include gene expression, screening, RNA interference and Vivo research, along with the bioproduction of viruses and proteins.

The increasing prevalence of cancer and various chronic lifestyle diseases is one of the key factors driving the growth of the market. Furthermore, widespread adoption of reagent-based methods is also providing a boost to the market growth. In comparison to the traditionally used techniques, reagent-based transfection is less complicated to administer and more cost-effective. In line with this, instrument-based methods, such as biolistic technology, microinjection and laserfection, are also gaining immense traction across the globe. Various technological advancements in cell research and therapeutic discovery are acting as another major growth-inducing factor. In line with this, research in gene transfer is majorly performed under in-vivo conditions for the development of novel therapeutic drugs and various other applications. Other factors, including increasing investments by both government and private organizations to develop large scale transfection facilities, along with extensive research and development (R&D) activities in the field of protein therapeutics, are projected to drive the market further.

Market Segmentation

This report provides an analysis of the key trends in each sub-segment of the global transfection technologies market report, along with forecasts at the global, regional and country level from 2026-2034. The report has categorized the market based on product type, application, transfection method, technology and end-user.

Breakup by Product Type

  • Reagent
  • Instrument
  • Others

Breakup by Application

  • Therapeutic Delivery
  • Bio-Medical Research
  • Protein Production
  • Others

Breakup by Transfection Method

  • Lipofection
  • Eletroporation
  • Nucleofection
  • Cotransfection
  • Cationic Lipid Transfection
  • In-Vivo Transfection
  • Others

Breakup by Technology

  • Physical Transfection
  • Biochemical Based Transfection
  • Viral-Vector Based Transfection

Breakup by End-User

  • Research Centers and Academic Institutes
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others

Breakup by Region

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Bio-RAD Laboratories Inc., Lonza Group AG, Maxcyte Inc., Mirus Bio LLC, Polyplus Transfection, Promega Corporation, Roche Holding AG, Sigma-Aldrich Corporation, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report

1. What was the size of the global transfection technologies market in 2025?

2. What is the expected growth rate of the global transfection technologies market during 2026-2034?

3. What are the key factors driving the global transfection technologies market?

4. What has been the impact of COVID-19 on the global transfection technologies market?

5. What is the breakup of the global transfection technologies market based on the product type?

6. What is the breakup of the global transfection technologies market based on the application?

7. What is the breakup of the global transfection technologies market based on the transfection method?

8. What is the breakup of the global transfection technologies market based on the technology?

9. What are the key regions in the global transfection technologies market?

10. Who are the key players/companies in the global transfection technologies market?10. Who are the key players/companies in the global transfection technologies market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Transfection Technologies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Reagent
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instrument
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Therapeutic Delivery
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Bio-Medical Research
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Protein Production
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Transfection Method

  • 8.1 Lipofection
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Eletroporation
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Nucleofection
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Cotransfection
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Cationic Lipid Transfection
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 In-Vivo Transfection
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by Technology

  • 9.1 Physical Transfection
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Biochemical Based Transfection
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Viral-Vector Based Transfection
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Research Centers and Academic Institutes
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Hospitals and Clinics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Pharmaceutical and Biotechnology Companies
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Agilent Technologies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Altogen Biosystems
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Amsbio
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Bio-RAD Laboratories Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Lonza Group AG
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Maxcyte Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Mirus Bio LLC
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Promega Corporation
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 QIAGEN N.V.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sartorius AG
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 SignaGen Laboratories
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Takara Bio Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Thermo Fisher Scientific Inc.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Transfection Technologies Market: Major Drivers and Challenges
  • Figure 2: Global: Transfection Technologies Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Transfection Technologies Market: Breakup by Product Type (in %), 2025
  • Figure 4: Global: Transfection Technologies Market: Breakup by Application (in %), 2025
  • Figure 5: Global: Transfection Technologies Market: Breakup by Transfection Method (in %), 2025
  • Figure 6: Global: Transfection Technologies Market: Breakup by Technology (in %), 2025
  • Figure 7: Global: Transfection Technologies Market: Breakup by End-User (in %), 2025
  • Figure 8: Global: Transfection Technologies Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Transfection Technologies (Reagent) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Transfection Technologies (Reagent) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Transfection Technologies (Instrument) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Transfection Technologies (Instrument) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Transfection Technologies (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Transfection Technologies (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Transfection Technologies (Therapeutic Delivery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Transfection Technologies (Therapeutic Delivery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Transfection Technologies (Bio-Medical Research) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Transfection Technologies (Bio-Medical Research) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Transfection Technologies (Protein Production) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Transfection Technologies (Protein Production) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Transfection Technologies (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Transfection Technologies (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Transfection Technologies (Lipofection) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Transfection Technologies (Lipofection) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Transfection Technologies (Eletroporation) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Transfection Technologies (Eletroporation) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Transfection Technologies (Nucleofection) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Transfection Technologies (Nucleofection) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Transfection Technologies (Cotransfection) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Transfection Technologies (Cotransfection) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Global: Transfection Technologies (Cationic Lipid Transfection) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Global: Transfection Technologies (Cationic Lipid Transfection) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Global: Transfection Technologies (In-Vivo Transfection) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: Global: Transfection Technologies (In-Vivo Transfection) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Global: Transfection Technologies (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Global: Transfection Technologies (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Global: Transfection Technologies (Physical Transfection) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Global: Transfection Technologies (Physical Transfection) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Global: Transfection Technologies (Biochemical Based Transfection) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Global: Transfection Technologies (Biochemical Based Transfection) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Global: Transfection Technologies (Viral-Vector Based Transfection) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Global: Transfection Technologies (Viral-Vector Based Transfection) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Global: Transfection Technologies (Research Centers and Academic Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Global: Transfection Technologies (Research Centers and Academic Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Global: Transfection Technologies (Hospitals and Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Global: Transfection Technologies (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Global: Transfection Technologies (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Global: Transfection Technologies (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Global: Transfection Technologies (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Global: Transfection Technologies (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: North America: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: North America: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: United States: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: United States: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Canada: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Canada: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Asia Pacific: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Asia Pacific: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: China: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: China: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Japan: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Japan: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: India: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: India: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: South Korea: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: South Korea: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Australia: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Australia: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Indonesia: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Indonesia: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Others: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Others: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Europe: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Europe: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Germany: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Germany: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: France: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: France: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 80: United Kingdom: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 81: United Kingdom: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 82: Italy: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 83: Italy: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Spain: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 85: Spain: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 86: Russia: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 87: Russia: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 88: Others: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 89: Others: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 90: Latin America: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 91: Latin America: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 92: Brazil: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 93: Brazil: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 94: Mexico: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 95: Mexico: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 96: Others: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 97: Others: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 98: Middle East and Africa: Transfection Technologies Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 99: Middle East and Africa: Transfection Technologies Market: Breakup by Country (in %), 2025
  • Figure 100: Middle East and Africa: Transfection Technologies Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 101: Global: Transfection Technologies Industry: SWOT Analysis
  • Figure 102: Global: Transfection Technologies Industry: Value Chain Analysis
  • Figure 103: Global: Transfection Technologies Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Transfection Technologies Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Transfection Technologies Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 3: Global: Transfection Technologies Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Transfection Technologies Market Forecast: Breakup by Transfection Method (in Million USD), 2026-2034
  • Table 5: Global: Transfection Technologies Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 6: Global: Transfection Technologies Market Forecast: Breakup by End-User (in Million USD), 2026-2034
  • Table 7: Global: Transfection Technologies Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 8: Global: Transfection Technologies Market Structure
  • Table 9: Global: Transfection Technologies Market: Key Players